×




Purinex, Inc. Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Purinex, Inc. case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Purinex, Inc. case study is a Harvard Business School (HBR) case study written by Robert F. Bruner, Sean Carr. The Purinex, Inc. (referred as “Purinex Pharmaceutical” from here on) case study provides evaluation & decision scenario in field of Finance & Accounting. It also touches upon business topics such as - Value proposition, .

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Purinex, Inc. Case Study


This is a Darden case study.In June 2004 Purinex, Inc., a pharmaceutical company with several clinically and commercially promising drugs in development, expected to secure a partnership with a major pharmaceutical company sometime in the next four to 12 months. That partnership, if secured, would enable Purinex to develop one of its leading compounds as a drug. The company, however, had no sales or earnings and only 11 months of cash on hand. The student must assess whether the company should attempt to secure financing now or wait until it consummated a partnership deal. The tasks for the student include evaluating the probabilities that a collaboration with a pharmaceutical company would actually happen; determining whether the company stay above water until such occurred; and analyzing the other risks to the company under these circumstances.


Case Authors : Robert F. Bruner, Sean Carr

Topic : Finance & Accounting

Related Areas :




Calculating Net Present Value (NPV) at 6% for Purinex, Inc. Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10010734) -10010734 - -
Year 1 3444079 -6566655 3444079 0.9434 3249131
Year 2 3965507 -2601148 7409586 0.89 3529287
Year 3 3946411 1345263 11355997 0.8396 3313483
Year 4 3237340 4582603 14593337 0.7921 2564276
TOTAL 14593337 12656178




The Net Present Value at 6% discount rate is 2645444

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Internal Rate of Return
2. Net Present Value
3. Payback Period
4. Profitability Index

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Purinex Pharmaceutical have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Purinex Pharmaceutical shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Purinex, Inc.

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Finance & Accounting Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Purinex Pharmaceutical often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Purinex Pharmaceutical needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10010734) -10010734 - -
Year 1 3444079 -6566655 3444079 0.8696 2994851
Year 2 3965507 -2601148 7409586 0.7561 2998493
Year 3 3946411 1345263 11355997 0.6575 2594829
Year 4 3237340 4582603 14593337 0.5718 1850960
TOTAL 10439133


The Net NPV after 4 years is 428399

(10439133 - 10010734 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10010734) -10010734 - -
Year 1 3444079 -6566655 3444079 0.8333 2870066
Year 2 3965507 -2601148 7409586 0.6944 2753824
Year 3 3946411 1345263 11355997 0.5787 2283803
Year 4 3237340 4582603 14593337 0.4823 1561217
TOTAL 9468910


The Net NPV after 4 years is -541824

At 20% discount rate the NPV is negative (9468910 - 10010734 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Purinex Pharmaceutical to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Purinex Pharmaceutical has a NPV value higher than Zero then finance managers at Purinex Pharmaceutical can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Purinex Pharmaceutical, then the stock price of the Purinex Pharmaceutical should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Purinex Pharmaceutical should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

Understanding of risks involved in the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What will be a multi year spillover effect of various taxation regulations.

What can impact the cash flow of the project.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Purinex, Inc.

References & Further Readings

Robert F. Bruner, Sean Carr (2018), "Purinex, Inc. Harvard Business Review Case Study. Published by HBR Publications.


Huaze Cobalt A SWOT Analysis / TOWS Matrix

Basic Materials , Misc. Fabricated Products


Youngor SWOT Analysis / TOWS Matrix

Consumer Cyclical , Apparel/Accessories


KNW SWOT Analysis / TOWS Matrix

Consumer Cyclical , Photography


Chambal Fertilisers SWOT Analysis / TOWS Matrix

Basic Materials , Chemical Manufacturing


Jiangsu High Hope SWOT Analysis / TOWS Matrix

Services , Retail (Department & Discount)


Hangzhou SWOT Analysis / TOWS Matrix

Technology , Software & Programming


Silvrcst As SWOT Analysis / TOWS Matrix

Financial , Investment Services


Exco Technologies SWOT Analysis / TOWS Matrix

Capital Goods , Misc. Capital Goods


Joincare Pharm SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs